Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medplus Health Services has informed exchanges that its subsidiary, Optival Health Solutions Private Limited, received a one-day suspension order for the drug license of its store at Vanasthalipuram Ganesh Temple in Telangana. The order was issued by the Assistant Director, Drugs Control Administration, Rangareddy, under Rule 65 of the Drugs and Cosmetics Act, 1940, and was received on December 30, 2025. The company has disclosed a potential revenue loss of approximately Rs 1.19 lakhs due to this one-day suspension. The order affects only a single store and is limited in duration, with no broader operational impact indicated.
The financial impact is negligible at around Rs 1.19 lakhs for a single store on a single day, and is unlikely to materially affect the company's overall operations or stock price. This appears to be a routine regulatory compliance matter disclosed under SEBI's disclosure requirements.